STAT3 and urinary bladder cancer: Since STAT3, a downstream target of COX2/PGE2, is involved in the regulation of primitive CK14+ cell expansion [47], we propose that in bladder cancer metformin inhibits CK14+ cell repopulation through the COX2/PGE2/STAT3 axis.